Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.
Current topics in therapeutic plasmapheresis.
[Multiple sclerosis: oral drugs].
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
The role of dendritic cells in autoimmunity.
Tumefactive multiple sclerosis in taiwan.
Autoantibodies to Potassium Channel KIR4.1 in Multiple Sclerosis.
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
Combined central and peripheral demyelination: A case description.
The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis.
[Sympathetic skin response and multiple sclerosis: Descriptive and prospective study, and association with neuroperineal disorders].
T2-relaxometry for myelin water fraction xtraction using wald distribution and extended phase graph.
Newer multiple sclerosis drugs and disability scores - are key data analyses missing?
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
Hypersensitivity Responses in the Central Nervous System.
Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study.
Nudging Oligodendrocyte Intrinsic Signaling to Remyelinate and Repair: Estrogen Receptor Ligand Effects.
Whole Transcriptome Screening Reveals Myelination Deficits in Dysplastic Human Temporal Neocortex.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.
Promising New Approaches to Assess Cognitive Functioning in People with Multiple Sclerosis.
Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.
Comparing adherence rates to disease modifying therapies for multiple sclerosis in commercial enrollees and Part D beneficiaries.
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells.

Pages